Significados de therapeutic fungicides en inglés

Treatment is hindered by the emergence of resistance to triazole antimycotic agents.

After initiation of antimycotic treatment the symptoms resolved completely.

The results of the antimicrobial assay showed that the presence of two amidic groups usually enhances antimycotic activity.

Our study demonstrates a variation of antimycotic and antifungal use in Europe, as striking as that of antibiotic use.

The progression of IFI despite antimycotic therapy illustrates the inherent problems of diagnosis and the need for innovative therapeutic modalities.

Intensive treatment with antifungal drugs was followed by remission of all symptoms.

This unexpected finding provides a new tool for generating antifungal drugs by biotransformation.

In contrast, antifungal drugs belonging to other chemical classes did not display inhibitory activity.

These proteins might represent a potential target for the development of innovative antifungal drugs.

This ex vivo study determined the extraction of antifungal drugs by the ECMO circuit.

No fungal organisms were isolated from HIV-positive patients under antifungal drug treatment.

It's certainly worth giving them a try before taking a potent antifungal drug.

However, there remains a paucity of antifungal drug treatments available to combat these fungal pathogens.

Our studies provide insights into the yeast-host environment interaction and identify potential antifungal drug targets.

The emergence of antifungal drug resistance is inevitable.

This study suggests that cranberry has potential as an antifungal agent.

This work validates HTA as an attractive drug-susceptible target for new antifungal agent design.

Infections were characterized by a chronic, indolent course requiring prolonged treatment with an antifungal agent.

Treatment consists in eradicating the causal fungus using an antifungal agent associated with symptomatic treatment.

Natamycin is a very attractive antifungal agent with wide applications in medical and food industries.

Broth microdilution-based susceptibility testing using six antifungal agents was also conducted.

This makes BPL an attractive drug target for new antifungal agents.

Furthermore, with widespread use of antifungal agents, drug-resistant fungal infections are on the rise.

It possesses several important features for development of antifungal agents.

In addition, the Company is engaged in the production of antibiotics and antifungal agents.